Sarepta Therapeutics Inc (LTS:0L35)
$ 121.67 0 (0%) Market Cap: 11.61 Bil Enterprise Value: 11.80 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 82/100

Sarepta Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript

Jun 16, 2021 / 02:30PM GMT
Release Date Price: $82 (-4.66%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Okay. Good morning, everybody. Thanks for joining us at the Bank of America Virtual Napa Conference. It's my pleasure this morning to have with us Sarepta as our next presenting company. For the next 50 minutes, I have the pleasure of speaking with Doug Ingram, who is President and Chief Executive Officer; as well as Ian Estepan, who is CFO. Doug and Ian, good morning. Thanks for joining us.

Douglas S. Ingram
Sarepta Therapeutics, Inc. - President, CEO & Director

Thank you for having us, Tazeen.

Ian Michael Estepan
Sarepta Therapeutics, Inc. - Executive VP & CFO

Thank you.

Tazeen Ahmad
BofA Securities, Research Division - VP

So we do hope to be back to Napa next year, but we're happy that you joined us virtually from Boston today.

Questions & Answers

Tazeen Ahmad
BofA Securities, Research Division - VP

So maybe for those that are listening, can you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot